Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ischemic Stroke,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07740018
What this trial is testing

Factors Affecting Clinical and Radiological Outcome in Endovascular Management of Acute Ischemic Stroke Due to Large Vessel Occlusion

Who this might be right for
Endovascular Thrombectomy
Sohag University 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07449910
What this trial is testing

Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial

Who this might be right for
Acute Ichemic StrokeAnterior Cerebral Artery StrokeBaricitinib
The First Affiliated Hospital of University of Science and Technology of China 750
Not applicableLooking for participantsNCT03153683
What this trial is testing

Brain, Blood And Clot or Tissue Registry And Collaboration

Who this might be right for
Acute Ischemic StrokeCerebrovascular Disorders
Justin Fraser 1,000
Not applicableStudy completedNCT03466372
What this trial is testing

Innovative Gait Biofeedback Strategies for Stroke Rehabilitation

Who this might be right for
Stroke, CardiovascularGait, Hemiplegic
Emory University 20
Not applicableLooking for participantsNCT04562194
What this trial is testing

NeVa ONE Registry Study

Who this might be right for
Acute Ischemic Stroke
Vesalio 600
Testing effectiveness (Phase 2)Looking for participantsNCT07375953
What this trial is testing

Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)

Who this might be right for
Ischemic Stroke
General Hospital of Shenyang Military Region 120
Not applicableStudy completedNCT04588337
What this trial is testing

INtravenous TNK for Acute isChemicsTroke in China

Who this might be right for
Stroke, Ischemic
General Hospital of Shenyang Military Region 1,000
Testing effectiveness (Phase 2)UnknownNCT06322394
What this trial is testing

BXOS110 Injection in the Treatment of Acute Ischaemic Stroke

Who this might be right for
Acute Ischemic Stroke
Biocells (Beijing) Biotech Co.,Ltd 300
Not applicableStudy completedNCT02446587
What this trial is testing

Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Who this might be right for
StrokeIschemic Stroke
The University of Texas Health Science Center, Houston 500
Large-scale testing (Phase 3)Looking for participantsNCT07517263
What this trial is testing

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 5,700
Testing effectiveness (Phase 2)WithdrawnNCT01849887
What this trial is testing

Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke

Who this might be right for
Ischemic Stroke
University of California, Irvine
Large-scale testing (Phase 3)Study completedNCT01758614
What this trial is testing

The Carotid and Middle Cerebral Artery Occlusion Surgery Study

Who this might be right for
Carotid Artery OcclusionMiddle Cerebral Artery OcclusionStroke
Xuanwu Hospital, Beijing 330
Not applicableUnknownNCT04674293
What this trial is testing

Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

Who this might be right for
The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health 500
Testing effectiveness (Phase 2)Study completedNCT03340493
What this trial is testing

Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)

Who this might be right for
Ischemic Stroke
Neuroscience Trials Australia 300
Large-scale testing (Phase 3)Study completedNCT00576693
What this trial is testing

Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis

Who this might be right for
Ischemic Stroke
Medical University of South Carolina 451
Not applicableActive Not RecruitingNCT05647577
What this trial is testing

The Relationship Between Inflammatory ARTritis and CArdiac DIseAse

Who this might be right for
Inflammatory ArthritisRheumatoid ArthritisSpondylitis, Ankylosing+12 more
University Hospital, Gentofte, Copenhagen 1,285
Testing effectiveness (Phase 2)Study completedNCT01014975
What this trial is testing

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Who this might be right for
Acute Ischemic Stroke
Grifols Therapeutics LLC 40
Not applicableStudy completedNCT05102877
What this trial is testing

Sensory Versus Motor Level Neuromuscular Electrical Stimulation

Who this might be right for
Stroke, Ischemic
Casa Colina Hospital and Centers for Healthcare 31
Large-scale testing (Phase 3)Looking for participantsNCT06994975
What this trial is testing

CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection

Who this might be right for
Acute Ischemic Stroke
Huashan Hospital 890
Testing effectiveness (Phase 2)Study completedNCT02671461
What this trial is testing

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

Who this might be right for
Thrombosis
Bristol-Myers Squibb 16
Next Page